Cartesian Therapeutics, Inc. (RNAC)
(Real Time Quote from BATS)
$26.24 USD
+1.64 (6.67%)
Updated May 22, 2024 10:54 AM ET
3-Hold of 5 3
F Value D Growth B Momentum F VGM
Brokerage Reports
0 items in cart
Cartesian Therapeutics, Inc. [RNAC]
Reports for Purchase
Showing records 1 - 4 ( 4 total )
Company: Cartesian Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Astellas Terminates Xork Collaboration; No Impact to Value; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: KAPOOR M
Company: Cartesian Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Descartes-08 Phase 2b Data in Mid-2024; 2023 Financials; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: KAPOOR M
Company: Cartesian Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
New Manufacturing Facility Should Drive Production Scale; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: KAPOOR M
Company: Cartesian Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
A New Formula for CAR-T in Autoimmunity; Assuming at Buy and $2 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: KAPOOR M
|